Drug: HEPARIN Injury: Internal haemorrhage Quarter: 2016Q3
Total Records: 8 Number of Pages: 1
Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
---|---|---|---|---|---|---|---|---|
124175504 | HEPARIN | Internal haemorrhage | JANSSEN | 57.60 YR | F | 0 | 20160913 | US |
126647502 | HEPARIN | Internal haemorrhage | SANDOZ | 50.00 YR | M | 0 | 20160913 | GB |
126705604 | HEPARIN | Internal haemorrhage | BRISTOL MYERS SQUIBB | 50.91 YR | M | 0 | 20160928 | GB |
126735161 | HEPARIN | Internal haemorrhage | SANDOZ | 50.00 YR | M | 0 | 20160822 | GB |
126829721 | HEPARIN | Internal haemorrhage | AUROBINDO | 0.00 | M | 0 | 20160825 | GB |
126830531 | HEPARIN | Internal haemorrhage | TEVA | 0.00 | M | 0 | 20160825 | GB |
126918402 | HEPARIN | Internal haemorrhage | INTERNATIONAL MEDICATION SYSTEM | 50.00 YR | M | 0 | 20160927 | GB |
127619661 | HEPARIN | Internal haemorrhage | AUROBINDO | 50.00 YR | M | 0 | 20160920 | GB |
Total Records: 8 Number of Pages: 1